Stryker (SYK) Non-Current Assets (2009 - 2026)
Stryker's (SYK) quarterly Non-Current Assets came in at $33.5 billion in Q2 2026, up 0.55% year-over-year from $33.3 billion in Q2 2025, and up 1.7% quarter-over-quarter from $33.0 billion in Q1 2026.
Analysis
Stryker (SYK) Non-Current Assets (2009 - 2026) Analysis & Trends
Stryker (SYK) has reported Non-Current Assets for 18 consecutive years, with $33.5 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Assets rose 0.55% year-over-year to $33.5 billion in Q2 2026; TTM through Jun 2026 was $132.9 billion, a 7.53% increase from a year earlier, with the FY2025 full-year figure at $33.1 billion, up 17.65% from the prior year.
- Non-Current Assets was $33.5 billion for Q2 2026 at Stryker, up from $33.0 billion in the prior quarter.
- Over five years, Non-Current Assets peaked at $33.5 billion in Q2 2026 and troughed at $26.6 billion in Q4 2022.
- A 5-year average of $29.3 billion and a median of $27.5 billion in 2024 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets fell 2.69% in 2023 and grew 21.26% in 2025, its largest moves.
- Over 5 years, Non-Current Assets stood at $26.6 billion in 2022, then grew by 2.95% to $27.4 billion in 2023, then advanced by 2.66% to $28.1 billion in 2024, then gained by 17.65% to $33.1 billion in 2025, then climbed by 1.28% to $33.5 billion in 2026.
- The last three Non-Current Assets figures came in at $33.5 billion (Q2 2026), $33.0 billion (Q1 2026), and $33.1 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 17.70 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.51 Bn |
| Mar 31, 2026 | 32.95 Bn |
| Dec 31, 2025 | 33.09 Bn |
| Sep 30, 2025 | 33.35 Bn |
| Jun 30, 2025 | 33.33 Bn |
| Mar 31, 2025 | 32.98 Bn |
| Dec 31, 2024 | 28.12 Bn |
| Sep 30, 2024 | 29.16 Bn |
| Jun 30, 2024 | 27.49 Bn |
| Mar 31, 2024 | 27.51 Bn |
| Dec 31, 2023 | 27.39 Bn |
| Sep 30, 2023 | 27.00 Bn |
| Jun 30, 2023 | 27.26 Bn |
| Mar 31, 2023 | 26.68 Bn |
| Dec 31, 2022 | 26.61 Bn |
| Sep 30, 2022 | 26.67 Bn |
| Jun 30, 2022 | 27.21 Bn |
| Mar 31, 2022 | 27.41 Bn |
| Dec 31, 2021 | 24.61 Bn |
| Sep 30, 2021 | 24.69 Bn |